In addition, we studied the effect of NM in another HCC cell line, SK-Hep-1, evaluating its efficacy on modulation of MMP-2 and -9, urokinase plasminogen activator (by fibrin zymography), and tissue inhibitors of metalloproteinases (by reverse zymography). Here, PLAU is linked to hepatocellular carcinoma.